Therapeutic Advances in Neurological Disorders (Nov 2008)

Natalizumab: benefit outweighs risk in selected patients with multiple sclerosis

  • J. Theodore Phillips,
  • Elliot M. Frohman

DOI
https://doi.org/10.1177/1756285608099124
Journal volume & issue
Vol. 1

Abstract

Read online

No abstracts available.